PMED - Profit Taking

Well I personally took profits yesterday, and today. I currently have very little left in (PMED) . The stock did have a extremely nice volume jump and price jump of late, but I see a long pullback before any major share price increase again. So, it's onto the next pick.

Terry

PMED - News! .027 High of the Day!

Wow, I'm still coming down from today. I was waiting for .009 to buy more and BOOM! PMED released a nice PR and it when from .0094 to .02 in about 5 minutes! Crazy stuff. Pennys are so tough to judge which is why I both love and hate them. I know PMED still had something left in it, however, I saw it going down below .0095 for a little while (not 10 minutes) before climbing again. I sat too long on the side and lost out on a bit of profit. Then I sucked it up and bought a bunch at .016 and .019.

Now it's all a matter of how great is the news? Where is the next level of resistance? When should I take profit? And the toughest thing of all is to remember to not be too greedy.

So, I'll take profit at .50 not 5.00. Heheh. Good luck with this runner everyone! Another great newsletter pick, which amazed even me. Enjoy the profits and the long weekend.

-Terry

PMED Still Looking Good To Me

I'm currently holding all of my shares of (PMED). Hoping for .02+ very soon. Today's volume was very nice to see. Although, I wish we'd break through .015 and show some strength. However, it appears we're dancing along the 10day trend line which is drawn in the chart below. This is the chart I must've refreshed about 100 times today as I watched it bounce off the drawn line.

PMED On The Brink Of A Great Run

We had a great surge today over .0135, which exactly what I was hoping for. I was also hoping for a close above .0135 though, which didn't happen. I do see there being a pretty good chance of having a great close to the week which could give us a nice jump Monday morning.

I have posted the 10 day intraday below for all you chart lovers.





Terry

Betting on PMED to Break Through

As I usually do with my picks...I put my money where my mouth is. I did sell some of (PMED) at around .009 and .0098, but have since bought back more at around .011 and .012. The strength appears to be increasing after all the profit taking. If we break through the recent high of .0135 I see a very nice run happening.

Good luck to (PMED)ers!

Terry

PMED: My Latest Buy

While I sold some of my (MAUG) and (FEMO) I am still holding them for at least a bit longer.

The latest one I like is (PMED). A very high risk play (being a sub-penny stock about 4 hours ago). However the high risk offers you the high reward.

Today (PMED) continued its fast upward trend ending the day up 41.03% at .011 with a high of .012. Not too shabby. I'm hoping for a nice gap on Monday after all those savvy traders out there notice this one on their momentum scans. That is where I found it, and I just couldn't resist the chart. It looked to be setting up for a very nice end of the week...and for that at least...I guessed right.

And now a look at the chart of (PMED) for the past 5 days.

Ain't that pretty!!!

-Terry

MAUG - The Run Has Begun!

We got some nice news of the completion of a merger this morning and (MAUG) is MOVING! Sure glad I got my post out yesterday to alert everyone before the jump. Hope some got in. Here is the news....

Maui General Store and Trinity BioGenics Complete Merger Agreement
HANA, Hawaii, Feb. 1, 2006 (PRIMEZONE) -- Maui General Store, Inc. (OTCBB:MAUG) and Palmera Holdings, Inc. dba Trinity BioGenics, announced today that the two companies have completed their agreement to merge as of January 24. Trinity BioGenics is a biotechnology company engaged in research and development of unique adult stem cell procedures and patient-specific immune therapies with applications for various conditions and diseases, with a current clinical focus on therapies for heart disease. "This is great news for Maui General Store shareholders," stated Maui General Store CEO Richard Miller, concluding that "Stem cell research and therapies may revolutionize the way medicine is conceived and practiced in the 21st Century."